Eli Lilly ( LLY 0.47%) has not performed well this year, with its shares down 13% to date. However, the company's stock ...

Eli Stowers could change positions when the former Vanderbilt football player goes to the NFL draft.

Preview this article 1 min The FDA approval of the GLP-1 pill also comes as the federal government is rolling out new ...

Foundayo, a once-daily oral GLP-1 medication approved for obesity and weight-related issues, ranges in cost from $25 to $349 ...

The weight loss segment is poised to generate lucrative profits for Eli Lilly.

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

The daily pill, called Foundayo, could make it easier for more people to lose weight.

U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its ...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

Eli Lilly (NYSE:LLY) has built one of the most remarkable growth stories in modern pharmaceutical history through its GLP-1 ...

Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill for FDA approval by the end of the year. The pill does not produce the same ...

The Food and Drug Administration on Wednesday approved Eli Lilly’s new GLP-1 daily pill called Foundayo. It's a new option ...